This inventor holds 1 USPTO granted patent. Top assignee: Case Western Reserve University. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Mark D Parker: Innovator in Hemolysis Detection
Introduction
Mark D Parker is an accomplished inventor based in Cleveland, OH (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of hemolysis through innovative methods and assays.
Latest Patents
Mark D Parker holds a patent for an "Assay and method for quantitating carbonic anhydrase activity and assessing red blood hemolysis." This patent describes a method and assay that utilize carbonic anhydrase (CA), specifically CA-I or CA-II, as a biomarker for hemolysis. The technique involves determining the percentage of erythrocyte hemolysis in a blood sample by quantifying the carbonic anhydrase present in the extracellular portion of the blood. This method serves to optimize therapeutic efficacy for treatments related to hemolysis. He has 1 patent to his name.
Career Highlights
Mark D Parker is affiliated with Case Western Reserve University, where he continues to advance research in the field of hemolysis detection. His work has the potential to significantly impact clinical practices and improve patient outcomes.
Collaborations
Some of his notable coworkers include Ryan R Geyer and Pan Zhao, who contribute to the collaborative efforts in research and development at the university.
Conclusion
Mark D Parker's innovative work in the detection of hemolysis through carbonic anhydrase assays showcases his commitment to advancing medical diagnostics. His contributions are paving the way for improved therapeutic strategies in treating hemolysis.